|
HS Code |
406402 |
| Product Name | Fmoc-Met(O2)-OH |
| Full Name | Fmoc-L-methionine sulfone |
| Molecular Formula | C19H19NO6S |
| Cas Number | 80807-57-0 |
| Appearance | White to off-white powder |
| Functional Groups | Fmoc (fluorenylmethyloxycarbonyl), sulfone, carboxylic acid, amino acid |
| Solubility | DMSO, DMF, limited in water |
| Purity | Typically ≥98% |
| Protecting Group | Fmoc |
| Storage Temperature | 2-8°C, dry place |
| Optical Activity | Typically supplied as L-isomer |
| Use | Fmoc-protected methionine sulfone for peptide synthesis |
As an accredited Fmoc-Met(O2)-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, opaque plastic bottle containing 5 grams of Fmoc-Met(O2)-OH powder, labeled with product details, safety information, and storage instructions. |
| Shipping | Fmoc-Met(O2)-OH is shipped in tightly sealed, moisture-proof containers under ambient temperature. It is protected from light, heat, and moisture during transit. The package includes safety labeling in compliance with chemical transportation regulations. Handling instructions and documentation are provided to ensure safe and efficient delivery to the destination laboratory. |
| Storage | **Storage for Fmoc-Met(O2)-OH:** Store Fmoc-Met(O2)-OH at 2–8 °C in a tightly sealed container, protected from light and moisture. Ensure the storage area is dry and well-ventilated. Avoid exposure to air and sources of contamination, as the compound may be sensitive to hydrolysis and oxidation. Keep away from incompatible substances such as strong acids, bases, or reducing agents. |
Applications of Fmoc-Met(O2)-OH in Industrial ManufacturingAs a dedicated producer of Fmoc-Met(O2)-OH, we supply this specialty compound to advanced manufacturers operating across the peptide synthesis and pharmaceutical development industries. The following applications detail real, industrial-scale implementation of this protected amino acid derivative and reflect our experience supporting process, quality, and compliance teams worldwide. 1. Solid Phase Peptide Synthesis (SPPS)Researchers and manufacturing teams rely on Fmoc-Met(O2)-OH as a protected methionine analog in SPPS to incorporate selectively oxidized methionine residues without undesired side reactions. Using our high-purity material allows for the preparation of complex peptide APIs and reference standards, particularly those requiring specific methionine sulfoxide motifs for therapeutic or analytical purposes. This substrate supports robust coupling and deprotection cycles on commercial synthesis equipment, meeting stringent in-process controls and validation norms set by global API supply chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Modified Therapeutic Peptide APIsBiopharmaceutical APIs increasingly require site-specific oxidative modifications, especially where methionine residues are deliberately oxidized for targeted efficacy or stability studies. Our raw material provides excellent batch-to-batch consistency and traceability, facilitating straightforward insertion of methionine sulfoxide at specific positions during scale-up. Pharmaceutical formulators can demonstrate impurity profiles and related substances per regulatory expectations, extending product value throughout clinical development pipelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Analytical Peptide Reference Standard ManufacturingContract testing laboratories and in-house QC teams require highly pure, structurally defined peptide reference standards containing methionine sulfoxide. Our product meets these demands by reducing side impurities that complicate mass spectrometry or chromatographic quantification. Analysts use our Fmoc-amino acid to precisely assemble calibration standards that ensure specification accuracy for regulatory release, with documented lot traceability supporting audit requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Bioconjugate Manufacturing for Diagnostic ResearchIndustrial diagnostic platforms need site-directed modification of peptide antigens and bioconjugates to improve assay reliability. By incorporating oxidized methionine residues with our Fmoc derivative, process teams enhance antigen-antibody differentiation and stability in immunochemistry formats. The exact chemical characteristics of the sulfoxide group increase peptide solubility and shelf life, directly impacting immunoassay performance and reproducibility across multiple diagnostic kit lots. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Fmoc-Met(O2)-OH prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Fmoc-Met(O2)-OH stands out as an inventive derivative among amino acid products, offering chemists a dependable choice for integrating methionine sulfone into peptide chains. In our plant, we approach every batch with a careful eye for consistency, emphasizing purity and traceability right back to the raw materials. Chemists who work at the bench know how difficult it becomes to work with oxidized residues. Whether for studying posttranslational modifications, generating therapeutic peptides, or tailoring model systems for protein studies, the practical utility of Fmoc-Met(O2)-OH continues to show real value.
Methionine oxidation often causes headaches for researchers aiming for precise modifications. We’ve focused our synthesis pathway on delivering Fmoc-Met(O2)-OH with a clear oxidation state — achieving sulfone rather than sulfoxide. This matters because sulfoxide forms (single oxidation) often revert or further oxidize under normal peptide conditions, whereas a full sulfone remains stable through harsh deprotection and coupling cycles. From the granular details of reaction monitoring, our approach avoids common pitfalls leading to material degradation or sulfoxide contamination.
Other approaches might offer semi-oxidized Fmoc-Met(O)-OH. Split oxidation sources and inconsistent handling can result in mixed populations that confuse bioanalytical assays. By going straight to the sulfone, our product maintains batch-to-batch reliability, so subsequent analytical work or scale-up runs do not encounter unpleasant surprises.
Fmoc-Met(O2)-OH does not just serve as another amino acid derivative; it offers a solution in projects that hinge on site-specific oxidation. In-house, purification combines HPLC with orthogonal verification by mass spectrometry. This method pinpoints trace impurities that could otherwise escape detection. For those who have run long peptide chains and discovered late-stage misincorporations due to micro-impurity, we understand the frustration. It is a waste of resources to lose a peptide batch at the cleavage stage due to an off-spec component.
The reality for those synthesizing therapeutic candidates or study tools: impurities often hide as ghosts through standard inspection. Only when independent assays begin to fail do subtle contaminants announce themselves. By running rigorous in-process controls, we cut out early problems rather than chasing them down the road.
In peptide synthesis, introducing Fmoc-Met(O2)-OH enables the mimicry of oxidative stress states or post-translational modifications seen in biological systems. Protein misfolding, signal transduction, cellular redox balance — each topic has demanded researchers build in methionine sulfone as a probe. We've worked with academic teams investigating neurodegenerative disease peptides and industry groups mapping oxidative liabilities in drug targets. The aim remains: offer a stable, high-purity material that reacts as expected in every coupling round.
Solid-Phase Peptide Synthesis (SPPS) protocols pose specific demands. Even minor changes in side chain protection can introduce unwanted truncations or diketopiperazine formation. Fmoc-Met(O2)-OH, with a side chain already locked in the oxidized sulfone state, resists further oxidation and keeps the chemistry straightforward. For downstream cyclization or bioconjugation, peptide engineers have found that introducing the sulfone variant allows selective labeling without worrying about unpredictable side reactions.
The Fmoc-Met(O2)-OH compound retains its white to off-white crystalline appearance, consistent with high-purity amino acid derivatives. The product adheres to precise HPLC retention measures, delivering sharp edges during quality checks. We measure not only the chemical purity but also check for optical rotation and moisture content, since these can deeply impact solid support loading and coupling efficiency. The molecular formula, C19H19NO6S, reflects the full oxidation of the thioether side chain.
Packed in light-resistant vials with integrated desiccant, the material lands on laboratory benches ready for immediate use in peptide synthesizers. Users dealing with scale-up batches benefit from uniform crystallinity that flows cleanly through automated dispensing, reducing manual intervention and downtime on peptide lines.
Over years of production, we’ve learned that methionine-based derivatives attract water, which can affect downstream coupling yields. Air monitoring with low-humidity handling spaces keeps the crystalline material free-flowing and dry. Direct shipment from sealed containers to gloveboxes or autosampler trays avoids unnecessary exposure, a common slip in less experienced workflows.
Solvent selection for initial dissolution also plays a big part in coupling efficiency. Simple DMF dissolution works for most protocols, but we've helped customers adjust to NMP or even DMSO for longer sequences prone to aggregation. These operational hints have come not from theory but from batches run at scale, where small errors multiply into substantial loss.
Comparisons arise with Fmoc-Met-OH and its other oxidized forms. The parent molecule, Fmoc-Met-OH, illustrates standard methionine with a non-oxidized thioether. It forms the baseline for most peptide synthesis, sensitive to oxidizing environments. Fmoc-Met(O)-OH, carrying the sulfoxide state, has seen fewer applications due to unpredictable reactivity — further oxidation can occur during synthesis or resin cleavage, changing the final peptide identity.
Fmoc-Met(O2)-OH, with its already fully oxidized sulfone state, stays unreactive toward common side-chain oxidants and persists through both acidic and basic washes. We have seen this help researchers design specific controls without the uncertainty of in situ oxidation. The stability window increases, so lengthy synthetic routes or multistep protocols do not suffer surprises at the purification stage.
N-Fmoc protection, standard in solid-phase assembly, shields the amino group without influencing the oxidized sulfur. This leaves the unique sulfone group free to serve as a versatile marker or bioconjugation handle. Our product’s particular quality comes from balancing this selectivity with overall integrity, monitored right from initial synthesis through final packaging.
Over the past decade, our experience manufacturing Fmoc-Met(O2)-OH at multiple scales has taught us the subtleties of large-batch versus research-quantity production. Facility controls — such as rigorous air exchange, trace oxygen monitoring, and specialized reactor linings — all play a part in keeping oxidation levels consistent. These investments come from repeated encounters with product off-color, unwanted odor profiles, and subtle purity drifts when overlooked.
Our process design eliminates cross-contamination with other sulfur-containing products, a challenge for facilities handling broad amino acid portfolios. Equipment is dedicated for oxidized methionine derivatives, with regular validation, so users receive only single-population material. For us, process discipline goes beyond paperwork. Lab checks routinely flag even minor anomalies, preventing flawed product from reaching the market.
Small differences, even in agitation speed or quench timing, influence yield or purity levels at harvest. Operators receive regular training to spot early signs of deviation, closing quality loops before issues compound. It can take extra hours on the shop floor, but those details return value in the reliability chemists expect at the bench.
Questions often arise among new users about the viability of Fmoc-Met(O2)-OH for long-chain peptides or complex conjugates. Through close collaboration with custom synthesis groups, we have seen the material incorporated into sequences exceeding 50 residues with no added truncations or chain deletions. Advanced HPLC and MS verification after synthesis consistently confirm full-length products.
For those working in the field, concerns about solubility and compatibility with different coupling agents (like HATU, PyBOP, or DIC/Oxyma) often come up. Field feedback has shown only minor differences from standard forms, and coupling rates remain robust across conditions. Special attention in the preparation phase — gentle warming or extended pre-dissolution — can smooth the transition for older synthesis platforms.
In early process transfer projects, we ran head-to-head trials comparing in situ oxidation with preformed Fmoc-Met(O2)-OH integration. Results favored the direct addition of the pure sulfone product, showing higher terminal yields and less variability in side product profiles. This stemmed from bypassing local oxidant heterogeneities or over-oxidation, which could destabilize sensitive peptide sequences downstream.
Even with high-purity material, real-world processes throw new problems: moisture picks up during weighing, accidental UV exposure, or cross-contamination from prior runs. By mapping out user workflows and digging into root cause, we’ve developed practical strategies to help chemists minimize risk. Routine recommendations include fast weighing under dry nitrogen, storage at controlled low temperatures, and transferring only what is needed for immediate synthesis.
Patience during scale-up pays dividends. Those transitioning from milligram screens to multi-gram projects need to re-examine solvent ratios and agitation times. Too much haste at the initial addition step can cause local clumping, lowering coupling rates. We encourage early pilot runs and provide both technical notes and troubleshooting consultations, based on actual lab experience, not distant theory.
Carrying out systematic washing after coupling improves sequence fidelity. Traces of unreacted Fmoc-Met(O2)-OH might stick on resin surfaces, especially those with hydrophilic or basic backbones. Analytically, we spot this as faintly trailing peaks in HPLC, often mistaken for less than full conversion. Increasing the number of washes or optimizing the cleavage chemistry clears these ambiguities in final product analysis.
Synthetic chemistry rarely unfolds without surprises. Direct feedback from long-term collaborators has shaped our continuous improvement. Each lot release brings scrutiny from users who run bioactivity screens or deploy peptides in complex matrices. Rapid response, accountability, and an openness to tweak protocols together show greater results than static specification sheets ever could.
The ability to engage directly with manufacturing chemists — not just sales representatives — gives users unique troubleshooting insight, cuts problem cycle times, and enables real progress when new peptide challenges surface. There have been occasions where unexpected resin interactions or novel side reactions show up, and having a manufacturing partner familiar with the origins of the molecule makes a lasting difference.
Some users have tried sourcing oxidized methionine derivatives through traders or broadline distributors, only to find subtle shifts in stability or analytical fingerprint. These gaps typically trace back to mixed-source product, inconsistent oxidation monitoring, or breaks in cold chain logistics. As a direct manufacturer, we have the infrastructure and system knowledge to prevent these risks.
In the drive for better peptide analogs and tailor-made research tools, requests have grown for Fmoc-Met(O2)-OH with even tighter purity specifications or special packaging. Working directly with researchers, we have piloted custom lot divisions, labeling changes for automated workflows, and flexible order sizes. Innovation often starts from talking shop with scientists who know their unique hurdles rather than applying generic models.
Environmental compliance influences raw material traceability and waste management. Our waste minimization projects capture not just spent solvents but sulfurous byproducts, ensuring they don't build in local ecosystems. Enhanced process controls mean less off-spec product, translating to sustainable efficiency alongside scientific gain.
Batch records carry complete synthesis, purification, and control history. This full documentation helps chemists faced with audits or who need absolute confidence in their starting materials, especially for regulated R&D pipelines or clinical research. Our digital systems, aligned to regulatory guidance, reduce errors and streamline access when researchers or QA teams request detailed backtracking.
As the field moves toward longer peptides, more complex libraries, and functionally tuned analogs, demand rises for specialty amino acids. The role of Fmoc-Met(O2)-OH expands beyond mere chemical curiosity; it anchors experiments that dissect the impact of pathological oxidation, uncover signal cascades, or create advanced drug delivery vectors.
With every batch, our team applies hands-on expertise, ensuring users spend less time troubleshooting and more time pushing their science forward. Investment in direct manufacturing capacity, analytical confidence, and user support will continue to grow with the next generation of peptide technology.
Peptide chemistry, at its best, depends on sturdy, transparent supply chains and partners who adapt as science advances. By building Fmoc-Met(O2)-OH on a foundation of real-world synthesis, precise monitoring, and open collaboration, we bring this essential specialty building block into the hands of those shaping the future of protein and peptide sciences.